One Advanced System
One Advanced System

System Benefits

Compared to stem cell allograft products

System Benefits

Compared to stem cell allograft products

More cells. less time. no spin.
Maximize stem cell count - in a fraction of the time.

Cumbersome, inefficient cell harvesting is now a thing of the past. The DirectCell System empowers surgeons to incorporate easy, spin-free stem cell aspirate (SCA1) harvesting into their surgical practice today, while delivering significantly higher cell counts than traditional centrifuge systems, Jamshidi needles, or cadaveric derived stem cells.2

  • Boost healing by harvesting significantly more stem cells per milliliter, using a true multi-directional harvesting system.
  • Patented screw mechanism easily and precisely repositions needle during harvest to maximize the number of stem cells collected.
  • Novel blocked tip design minimizes the collection of peripheral blood, eliminating the need to centrifuge and saving valuable time.
Gold standard autograft with less morbidity.

Cortical bone autograft contains minimal cellular content. Improve autograft quality by harvesting marrow-rich cancellous dowels, that:

  • Contain intact microvasculature that accelerates bone regeneration.5,6
  • Are rich in marrow and filled with live stem cells, providing osteoconductive, osteoinductive, and osteogenic power for bone healing.
  • Minimize donor site morbidity through the use of a percutaneous harvesting technique.
Engineered to promote a biological response.

Agilon® Advanced Synthetic Bone Graft works in harmony with autologous stem cells. Its next-generation TrelCor® granules, which feature nanosized surface architecture and morphology, provide a unique surface for cell attachment that leads to bone formation.7*

  • Advanced, regenerative technology in every granule.
  • Designed to play an active role in bone regeneration.
  • Densely packed with granules to maximize contact with bone.
  • Innovation backed by over 50,000 successful cases.
The DirectCell Systems are available with Agilon Moldable or Agilon Strip Advanced Bone Graft, in the following configurations:

Have a question about
the DirectCell System?

Have a question about the DirectCell System?
Contact Us
TEXT “CELL” TO
833-231-3791
REFERENCES:

1. Stem cell aspirate (SCA) is a type of BMA with higher stem cell counts and is referenced as “BMA” in FDA clearances.
2. Scarpone MA, et al. Marrow Cellution Bone Marrow Aspiration System and Related Concentrations of Stem and Progenitor Cells. White Paper (2015).
3. Harrell DB, et al. Novel Technology to Increase Concentrations of Stem and Progenitor Cells from Marrow Aspiration. White Paper (2016).
4. McLain R, et al. J Bone Joint Surg Am. 87(12):2655-61 (2005).
5. Ostrup LT, et al. Plast Reconstr Surg. 54(3):274-85 (1974).
6. Taylor GI, et al. Plast Reconstr Surg. 55(5):533-544 (1975).
7. Borden MD, et al. J Biomed Mater Res B Appl Biomater. 2024;112(5):e35416.
* Pre-clinical test data are not necessarily indicative of clinical performance.

1. Stem cell aspirate (SCA) is a type of BMA with higher stem cell counts and is referenced as “BMA” in FDA clearances.
2. Scarpone MA, et al. Marrow Cellution Bone Marrow Aspiration System and Related Concentrations of Stem and Progenitor Cells. White Paper (2015).
3. Harrell DB, et al. Novel Technology to Increase Concentrations of Stem and Progenitor Cells from Marrow Aspiration. White Paper (2016).
4. McLain R, et al. J Bone Joint Surg Am. 87(12):2655-61 (2005).
5. Ostrup LT, et al. Plast Reconstr Surg. 54(3):274-85 (1974).
6. Taylor GI, et al. Plast Reconstr Surg. 55(5):533-544 (1975).
7. Borden MD, et al. J Biomed Mater Res B Appl Biomater. 2024;112(5):e35416.
* Pre-clinical test data are not necessarily indicative of clinical performance.

Back To Top